Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy

Journal of Clinical Rheumatology

Volumn 7, Issue 4, 2001, Pages 252-256

  Stern, Alan ^b   Riley, Roger ^b   Buckley, Lenore ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Adult onset systemic juvenile rheumatoid arthritis; Cyclosporine A; Etanercept; Macrophage activation syndrome; Tumor necrosis factor

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; ETANERCEPT; GOLD; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; MACROPHAGE ACTIVATION; PANCYTOPENIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0034884145     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200108000-00013     Document Type: Article

References (21)

1. Diagnostic guidelines for hemophagocytic lymphohistiocytosis
2. Virus-associated hemophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis
3. Acute hemorrhagic, hepatic, and neurological manifestations in JRA: Possible relationship to drugs and infections
4. Still's disease associated with coxsackie infection and hemophagocytic syndrome
5. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine
6. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases
7. Adult onset Still's disease associated hemophagocytosis
8. Still's disease and the virus-associated hemophagocytic syndrome
9. Macrophage activation syndrome and rheumatic disease in childhood: A report of four new cases
10. Hyperferritinemia in adult onset Still's disease and hemophagocytic syndrome
11. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
12. The role of tumor necrosis factor in health and disease
13. Soluble tumor necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis
14. Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome
15. Etanercept in children with polyarticular juvenile rheumatoid arthritis
16. Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumor necrosis factor-alpha
17. Safety and efficacy of high dose etanercept in the treatment of juvenile rheumatoid arthritis (JRA)
18. Variable response of systemic juvenile rheumatoid arthritis to etanercept
19. Treatment of systemic JRA with etanercept: Results of a survey
20. Use of etanercept in the treatment of macrophage activation syndrome
21. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors